In this issue of the EDGE:

At 3D we tell our clients it’s not only what you say in business, it’s how you say it. Of course, that old adage can apply to your personal life as well. Find out how your voice can reveal whether you’re "meant" for each other, or not.
Read more>

While many of us may be worried about the size of our gut, most GI doctors are worried about its health. Take the Core Score Quiz to get your digestive tract, back on track.
Read more>


Congratulations to Procter & Gamble for winning the Publicity Club of Chicago’s prestigious Golden Trumpet Award. The video, produced by 3D Communications, was about the company’s new technology to purify contaminated water in the developing world.
Read more>

 


Taking Your Drug From Rx-to-OTC Part II:
How to Win with the FDA Advisory Committee

“Drug companies, third party payers and regulators will continue to push to switch products to over-the-counter status, especially with 15 blockbuster drugs (annual sales more than $1 billion) due to lose patent protection through 2008.”
-Tufts Center for the Study of Drug Development, Outlook 2004


Despite increasing pressure from all stakeholders to make prescription drugs more accessible to consumers, the FDA approval process for an Rx-to-OTC switch is as rigorous as ever. Most proposed switches still have to leap that critical final hurdle in the FDA approval process: the advisory committee hearing.

In the second part of a two-part series,
(click here for Part I) a regulatory expert from the Consumer Healthcare Products Association and a physician-scientist with 20 years experience at NIH offer frank advice to pharmaceutical companies on how to prepare for the FDA advisory committee hearing. Learn how to increase your odds of receiving a positive recommendation.
Read more>